Pluslife recently unveiled its state-of-the-art molecular POCT solution at the 45^th Annual Conference of the Association of Medical Technologists of Thailand (ACMTT). Solutions for Sexual Transmitted Diseases (STIs) to advance patient outcomes in Clinics were highlighted during the event. On-site visitors provided valuable feedback and eagerly engaged in discussions with experts from Pluslife.

The ACMTT is organized by the esteemed Thai Medical Technology Association, renowned for its rich 60-year history and significant authority in the field of medical technology. The primary objective of ACMTT 2023 is to share the latest information and foster effective communication within the industry. By inviting leading companies worldwide, ACMTT 2023 attracted approximately 3000 visitors to attend and explore advances in medical equipment and technology.

Pluslife Next-Generation Molecular POCT technology has made advancements in STI testing and treatment across various aspects. Primary healthcare facilities such as clinics can set up NAAT with low costs and minimal resources as Pluslife Mini Dock analyzer has a strong cost advantage over competitors and does not require specialized personnel for operation. Additionally, STD patients now have faster testing options for regular checkups. Rather than relying solely on hospital PCR tests that are generally longer than 24 hours, the Pluslife Mini Dock analyzer provides results within 30 minutes, enabling patients to receive same-day diagnosis and treatment in as short as 1 hour. 

Aside from the STIs product demonstration, Pluslife conducted an informative workshop as part of the exhibition and guided attendees to delve deeper into the Next-Generation Molecular POCT Solution. With the introduction of Pluslife self-developed patented RHAM isothermal amplification technology and its product advantages in comparison with competitors, the Pluslife products gained recognition from audiences and resulted in a highly interactive Question and Answer section that facilitated discussions on how to localize molecular POCT in Thailand healthcare facilities.

Tailored for healthcare services in Thailand, Pluslife SIT products have gained rapid acceptance in the market. Pluslife dedicates to localizing the application of molecular POCT and equipping local residents with comprehensive knowledge of infectious diseases management, particularly focusing on STD diagnosis and treatment. In the near future, Pluslife will continue to make contributions to alleviate primary medical diagnosis burdens in Thailand.